Status post cadaveric renal transplant.
The patient has been on hemodialysis since [**2145-8-1**].
Autoimmune glomerulonephritis.
Status post coronary artery stenting.
Aspirin 81 mg q day.
Lipitor 20 mg q day.
Digoxin 0.125 mg qod.
Amiodarone 200 mg q day.
Colchicine 0.6 mg q day.
Lopressor 12.5 mg [**Hospital1 **].
Iron supplement.
HOSPITAL COURSE:  The patient was admitted on [**2146-6-18**] for cadaveric renal transplant.
He had his renal transplant implanted into the right ileac fossa.
Multiple Foley attempts were made, ultimately Urology was consulted and placed a 24 French [**Doctor Last Name **]-way coude catheter for continuous bladder irrigation.
Patient was restarted on amiodarone as well as a beta blocker in junction with Cardiology consultation.
The patient was given intravenous fluids per protocol at 50 cc an hour, plus 1 cc/cc of urine output greater than 50 cc.
From an infectious disease standpoint, the patient was prophylaxed with Valcyte 450 mg qod as well as nystatin 5 mL qid.
The patient has an allergy to Bactrim and will undergo pentamidine inhalation therapy.
From an immunosuppression standpoint, the patient was given a rapid taper Solu-Medrol dosing, three doses of thyroglobulin, CellCept 1,000 mg [**Hospital1 **], and was ultimately discharged on Neoral dose of 350 mg [**Hospital1 **].
The patient did have some electrolyte abnormalities which were treated and trending in the correct direction upon discharge.
These were treated aggressively with calcium repletion as well as PhosLo three caps tid.
Patient may undergo another hemodialysis treatment potentially on Wednesday, [**2146-6-29**].
